Atlas Trials

Real World Study of Regorafenib Versus Fruquintinib in Colorectal Cancer

Clinical trial NCT04431791 · UNKNOWN

Trial details

NCT number
NCT04431791
Sponsor
Peking University
Status
UNKNOWN
Study type
OBSERVATIONAL
Colorectal Cancer
Start date
2020-05-25
Primary completion
2021-08-01
Enrollment
268

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.